Robert E. Gagnon Verastem, Inc. (VSTM) insider trading activity

VSTM Quotes by TradingView

Robert E. Gagnon is Director of Verastem, Inc.. Currently has a direct ownership of 41,678 shares of VSTM, which is worth approximately $321,337. The most recent transaction as insider was on Dec 16, 2025, when has been sold 283 shares (Common Stock) at a price of $9.14 per share, resulting in proceeds of $2,586. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.7K
0.67% 3M change
20.89% 12M change
Total Value Held $321,337

Robert E. Gagnon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2025
SELL
Open market or private sale
$2,586 $9.14 p/Share
283 Reduced 0.67%
41,678 Common Stock
Sep 16 2025
SELL
Open market or private sale
$2,807 $9.99 p/Share
281 Reduced 0.67%
41,961 Common Stock
Jun 16 2025
SELL
Open market or private sale
$1,604 $5.65 p/Share
284 Reduced 0.67%
42,242 Common Stock
May 22 2025
BUY
Grant, award, or other acquisition
-
8,333 Added 16.38%
42,526 Common Stock
Mar 17 2025
SELL
Open market or private sale
$1,973 $6.95 p/Share
284 Reduced 0.82%
34,193 Common Stock
Dec 19 2024
SELL
Open market or private sale
$568 $4.37 p/Share
130 Reduced 0.38%
34,477 Common Stock
Dec 16 2024
SELL
Open market or private sale
$1,293 $4.54 p/Share
285 Reduced 0.82%
34,607 Common Stock
Sep 19 2024
SELL
Open market or private sale
$365 $2.79 p/Share
131 Reduced 0.37%
34,892 Common Stock
Sep 16 2024
SELL
Open market or private sale
$803 $2.8 p/Share
287 Reduced 0.81%
35,023 Common Stock
Jun 20 2024
SELL
Open market or private sale
$420 $3.21 p/Share
131 Reduced 0.37%
35,310 Common Stock
Jun 18 2024
BUY
Grant, award, or other acquisition
-
8,333 Added 19.04%
35,441 Common Stock
Jun 17 2024
SELL
Open market or private sale
$987 $3.49 p/Share
283 Reduced 1.03%
27,108 Common Stock
Mar 19 2024
SELL
Open market or private sale
$1,349 $10.38 p/Share
130 Reduced 0.47%
27,391 Common Stock
Mar 18 2024
SELL
Open market or private sale
$3,030 $10.71 p/Share
283 Reduced 1.02%
27,521 Common Stock
Feb 06 2024
SELL
Open market or private sale
$126,094 $13.7 p/Share
9,204 Reduced 24.87%
27,804 Common Stock
Jan 12 2024
SELL
Open market or private sale
$100,783 $10.95 p/Share
9,204 Reduced 19.92%
37,008 Common Stock
Dec 19 2023
SELL
Open market or private sale
$1,004 $7.73 p/Share
130 Reduced 0.28%
46,212 Common Stock
Dec 18 2023
SELL
Open market or private sale
$2,169 $7.64 p/Share
284 Reduced 0.61%
46,342 Common Stock
Sep 19 2023
SELL
Open market or private sale
$1,279 $9.84 p/Share
130 Reduced 0.28%
46,626 Common Stock
Sep 18 2023
SELL
Open market or private sale
$2,754 $9.91 p/Share
278 Reduced 0.59%
46,756 Common Stock
Jun 20 2023
SELL
Open market or private sale
$1,339 $10.3 p/Share
130 Reduced 0.28%
47,034 Common Stock
Jun 16 2023
SELL
Open market or private sale
$2,807 $9.92 p/Share
283 Reduced 0.6%
47,164 Common Stock
Mar 20 2023
SELL
Open market or private sale
$715 $0.43 p/Share
1,664 Reduced 0.29%
569,399 Common Stock
Mar 16 2023
SELL
Open market or private sale
$1,461 $0.4 p/Share
3,654 Reduced 0.64%
571,063 Common Stock
Dec 19 2022
SELL
Open market or private sale
$528 $0.37 p/Share
1,429 Reduced 0.25%
574,717 Common Stock

Also insider at

BBLG
Bone Biologics Corp Healthcare
Director
HBIO
HARVARD BIOSCIENCE INC Healthcare
Director
OCUP
Ocuphire Pharma, Inc. Healthcare
Chief Financial Officer
REG

Robert E. Gagnon

Director
Needham, MA

Track Institutional and Insider Activities on VSTM

Follow Verastem, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VSTM shares.

Notify only if

Insider Trading

Get notified when an Verastem, Inc. insider buys or sells VSTM shares.

Notify only if

News

Receive news related to Verastem, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VSTM